肠杆菌科细菌性肝脓肿的病理生理机制: 从肠道定植到全身耗竭
Pathophysiological Mechanisms of Enterobacteriaceae-Associated Pyogenic Liver Abscess: From Intestinal Colonization to Systemic Exhaustion
DOI: 10.12677/acm.2026.1631153, PDF,   
作者: 杜连聪, 阿永俊*:昆明医科大学研究生院,云南 昆明;金文祥:昆明医科大学第二附属医院肝胆胰外科,云南 昆明
关键词: 细菌性肝脓肿细菌易位定植肠–肝轴细胞因子风暴免疫营养耗竭治疗Pyogenic Liver Abscess (PLA) Bacterial Translocation and Colonization Gut-Liver Axis Cytokine Storm Immunometabolic Exhaustion Therapy
摘要: 细菌性肝脓肿(PLA)是由细菌引起的严重感染性疾病,其发病率及不良预后风险近年来持续上升,尤以高毒力肺炎克雷伯菌和产ESBLs菌株为主要挑战。研究显示,肠道菌群失调及肠屏障破坏促使细菌经门静脉易位至肝脏,是肝脓肿发生的起始环节;随后肠–肝轴双向紊乱加剧炎症反应并形成恶性循环。感染失控可触发以细胞因子风暴为特征的全身炎症反应综合征,继而导致淋巴细胞减少、免疫功能抑制及营养代谢耗竭,最终进展为脓毒症和多器官功能障碍。本文系统综述了肠杆菌科细菌性肝脓肿从肠道定植到全身免疫营养耗竭的病理生理机制,并探讨了微生物调节、免疫调控及强化营养支持等辅助治疗策略,为优化临床管理和改善预后提供理论依据。
Abstract: Pyogenic liver abscess (PLA) is a severe bacterial infection, whose incidence and risk of poor prognosis have been on the rise in recent years. Hypervirulent Klebsiella pneumoniae and extended-spectrum β-lactamase (ESBLs)-producing strains pose the most prominent challenges in this regard. Studies have demonstrated that intestinal dysbiosis and intestinal barrier disruption facilitate bacterial translocation to the liver via the portal vein, which constitutes the initial step in the development of liver abscess. Subsequent bidirectional dysfunction of the gut-liver axis exacerbates the inflammatory response and forms a vicious cycle. Uncontrolled infection can trigger systemic inflammatory response syndrome (SIRS) characterized by cytokine storm, which in turn leads to lymphopenia, immunosuppression, and metabolic exhaustion. The condition may eventually progress to sepsis and multiple organ dysfunction syndrome (MODS). This review systematically summarizes the pathophysiological mechanisms of Enterobacteriaceae-associated pyogenic liver abscess, ranging from intestinal colonization to systemic immunometabolic exhaustion, and further discusses adjuvant therapeutic strategies such as microbial modulation, immunoregulation, and intensive nutritional support. It is expected to provide a theoretical basis for optimizing clinical management and improving patient prognosis.
文章引用:杜连聪, 金文祥, 阿永俊. 肠杆菌科细菌性肝脓肿的病理生理机制: 从肠道定植到全身耗竭[J]. 临床医学进展, 2026, 16(3): 3468-3478. https://doi.org/10.12677/acm.2026.1631153

参考文献

[1] Zhang, J., Gao, Y., Du, Z., Ren, Y., Bi, J., Wu, Z., et al. (2021) Clinical Features and Prognosis of Gas-Forming and Non-Gas-Forming Pyogenic Liver Abscess: A Comparative Study. Surgical Infections, 22, 427-433. [Google Scholar] [CrossRef] [PubMed]
[2] 惠鹏, 朱鹏, 廖威, 等. 细菌性肝脓肿菌群分布与耐药性分析的多中心回顾性研究(附897例报告) [J]. 中华消化外科杂志, 2019, 18(10): 924-933.
[3] Long, Q., Zhao, X., Chen, C., Hao, M. and Qin, X. (2024) Clinical Features and Risk Factors for Pyogenic Liver Abscess Caused by Multidrug-Resistant Organisms: A Retrospective Study. Virulence, 15, Article ID: 2356680. [Google Scholar] [CrossRef] [PubMed]
[4] You, X., Wang, L., Wang, H., Xu, Y., Chen, Y., Xu, H., et al. (2024) Liver Abscess Induced by Intestinal Hypervirulent Klebsiella pneumoniae through Down-Regulation of Tryptophan-IPA-IL22 Axis. iScience, 27, Article ID: 110849. [Google Scholar] [CrossRef] [PubMed]
[5] Lin, H., Liao, K., Chang, C., Lin, C. and Lai, S. (2017) Correlation between Proton Pump Inhibitors and Risk of Pyogenic Liver Abscess. European Journal of Clinical Pharmacology, 73, 1019-1025. [Google Scholar] [CrossRef] [PubMed]
[6] Tsiaoussis, G.I. (2015) Intestinal Barrier Dysfunction in Cirrhosis: Current Concepts in Pathophysiology and Clinical Implications. World Journal of Hepatology, 7, 2058-2068. [Google Scholar] [CrossRef] [PubMed]
[7] Han, J., Yu, H., Xue, H., Lu, Y., Li, S., Zhang, Q., et al. (2025) Disentangling the Causal Role of Gut Microbiota in Bacterial Liver Abscess: A Mendelian Randomization Study with Clinical Validation. Pathogens, 14, Article 1173. [Google Scholar] [CrossRef
[8] Chen, N., Ling, Z., Jin, T., Li, M., Zhao, S., Zheng, L., et al. (2018) Altered Profiles of Gut Microbiota in Klebsiella pneumoniae-Induced Pyogenic Liver Abscess. Current Microbiology, 75, 952-959. [Google Scholar] [CrossRef] [PubMed]
[9] Hoh, C.H., Tan, Y.H. and Gan, Y. (2019) Protective Role of Kupffer Cells and Macrophages in Klebsiella pneumoniae-Induced Liver Abscess Disease. Infection and Immunity, 87, e00369-19. [Google Scholar] [CrossRef] [PubMed]
[10] Lee, C., Lee, J.H., Park, K.S., Jeon, J.H., Kim, Y.B., Cha, C., et al. (2017) Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms. Frontiers in Cellular and Infection Microbiology, 7, Article 483. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, H., Chen, L., Wang, C. and Chang, Z. (2025) Neutrophil Extracellular Trap-Borne C3-Driven Endothelial Dysfunction in Klebsiella pneumoniae Liver Abscess. Virulence, 16, Article ID: 2580104. [Google Scholar] [CrossRef
[12] Hullahalli, K., Dailey, K.G., Hasegawa, Y., Torres, E., Suzuki, M., Zhang, H., et al. (2023) Genetic and Immune Determinants of E. coli Liver Abscess Formation. Proceedings of the National Academy of Sciences of the United States of America, 120, e2310053120. [Google Scholar] [CrossRef] [PubMed]
[13] Ma, L., Wang, H., Jin, Q., Sun, Z., Yu, S. and Zhang, Y. (2025) The Gut-Liver Axis: Molecular Mechanisms and Therapeutic Targeting in Liver Disease. International Journal of General Medicine, 18, 7531-7546. [Google Scholar] [CrossRef
[14] Wang, T., Yu, H., Yu, J., et al. (2024) Research Progress in the Mechanism of Intestinal Environmental Disturbance on the Occurrence and Development of Sepsis-Associated Liver Injury. Chinese Critical Care Medicine, 36, 660-663.
[15] 肖红艳, 梁华平, 朱俊宇. 肠-肝互作在感染性肠/肝损伤中的作用及机制[J]. 中华危重病急救医学, 2024, 36(6): 656-659.
[16] Tripathi, A., Debelius, J., Brenner, D.A., Karin, M., Loomba, R., Schnabl, B., et al. (2018) The Gut-Liver Axis and the Intersection with the Microbiome. Nature Reviews Gastroenterology & Hepatology, 15, 397-411. [Google Scholar] [CrossRef] [PubMed]
[17] Walker, K.A. and Miller, V.L. (2020) The Intersection of Capsule Gene Expression, Hypermucoviscosity and Hypervirulence in Klebsiella pneumoniae. Current Opinion in Microbiology, 54, 95-102. [Google Scholar] [CrossRef] [PubMed]
[18] Kumar, M., Leon Coria, A., Cornick, S., Petri, B., Mayengbam, S., Jijon, H.B., et al. (2020) Increased Intestinal Permeability Exacerbates Sepsis through Reduced Hepatic SCD-1 Activity and Dysregulated Iron Recycling. Nature Communications, 11, Article No. 483. [Google Scholar] [CrossRef] [PubMed]
[19] Shi, L., Jin, L. and Huang, W. (2023) Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases. Cells, 12, Article 1888. [Google Scholar] [CrossRef] [PubMed]
[20] Liu, Z., Li, N., Fang, H., Chen, X., Guo, Y., Gong, S., et al. (2019) Enteric Dysbiosis Is Associated with Sepsis in Patients. The FASEB Journal, 33, 12299-12310. [Google Scholar] [CrossRef] [PubMed]
[21] Kumar, V. (2020) Toll-Like Receptors in Sepsis-Associated Cytokine Storm and Their Endogenous Negative Regulators as Future Immunomodulatory Targets. International Immunopharmacology, 89, Article ID: 107087. [Google Scholar] [CrossRef] [PubMed]
[22] Gong, T., Liu, L., Jiang, W. and Zhou, R. (2019) DAMP-Sensing Receptors in Sterile Inflammation and Inflammatory Diseases. Nature Reviews Immunology, 20, 95-112. [Google Scholar] [CrossRef] [PubMed]
[23] Stortz, J.A., Mira, J.C., Raymond, S.L., Loftus, T.J., Ozrazgat-Baslanti, T., Wang, Z., et al. (2018) Benchmarking Clinical Outcomes and the Immunocatabolic Phenotype of Chronic Critical Illness after Sepsis in Surgical Intensive Care Unit Patients. Journal of Trauma and Acute Care Surgery, 84, 342-349. [Google Scholar] [CrossRef] [PubMed]
[24] Drewry, A.M., Samra, N., Skrupky, L.P., Fuller, B.M., Compton, S.M. and Hotchkiss, R.S. (2014) Persistent Lymphopenia after Diagnosis of Sepsis Predicts Mortality. Shock, 42, 383-391. [Google Scholar] [CrossRef] [PubMed]
[25] 刘红升, 张庆红. GLP-1调控脓毒症T淋巴细胞功能障碍的免疫代谢机制研究进展[J]. 解放军医学杂志, 2025, 50(4): 483-489.
[26] Mazer, M.B., C. Caldwell, C., Hanson, J., Mannion, D., Turnbull, I.R., Drewry, A., et al. (2021) A Whole Blood Enzyme-Linked Immunospot Assay for Functional Immune Endotyping of Septic Patients. The Journal of Immunology, 206, 23-36. [Google Scholar] [CrossRef] [PubMed]
[27] Ertel, W., Kremer, J., Kenney, J., Steckholzer, U., Jarrar, D., Trentz, O., et al. (1995) Downregulation of Proinflammatory Cytokine Release in Whole Blood from Septic Patients. Blood, 85, 1341-1347. [Google Scholar] [CrossRef
[28] Shen, Y., He, Y., Pan, Y., Liu, L., Liu, Y. and Jia, J. (2024) Role and Mechanisms of Autophagy, Ferroptosis, and Pyroptosis in Sepsis-Induced Acute Lung Injury. Frontiers in Pharmacology, 15, Article 1415145. [Google Scholar] [CrossRef] [PubMed]
[29] Silva, E.E., Skon-Hegg, C., Badovinac, V.P. and Griffith, T.S. (2023) The Calm after the Storm: Implications of Sepsis Immunoparalysis on Host Immunity. The Journal of Immunology, 211, 711-719. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, J.D.J., Suan, E., Li, S.S. and Shelat, V.G. (2025) Sepsis and the Diverse Organ-Gastrointestinal Tract Axis. World Journal of Critical Care Medicine, 14, Article ID: 105547. [Google Scholar] [CrossRef
[31] Abhari, K., Shekarforoush, S.S., Sajedianfard, J., et al. (2015) The Effects of Probiotic, Prebiotic and Synbiotic Diets Containing Bacillus coagulans and Inulin on Rat Intestinal Microbiota. Iranian Journal of Veterinary Research, 16, 267-273.
[32] McQuade, J.L., Ologun, G.O., Arora, R. and Wargo, J.A. (2020) Gut Microbiome Modulation via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers. Current Oncology Reports, 22, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[33] 王婷婷, 秦海东. 脓毒症相关细胞因子风暴的机制与治疗策略[J]. 基础医学与临床, 2025, 45(2): 263-267.
[34] Galván-Román, J.M., Rodríguez-García, S.C., Roy-Vallejo, E., et al. (2021) IL-6 Serum Levels Predict Severity and Response to Tocilizumab in COVID-19: An Observational Study. Journal of Allergy and Clinical Immunology, 147, 72-80.e78.
[35] Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., et al. (2020) Baricitinib Restrains the Immune Dysregulation in Patients with Severe Covid-19. Journal of Clinical Investigation, 130, 6409-6416. [Google Scholar] [CrossRef] [PubMed]
[36] Ono, Y., Maejima, Y., Saito, M., Sakamoto, K., Horita, S., Shimomura, K., et al. (2020) TAK-242, a Specific Inhibitor of Toll-Like Receptor 4 Signalling, Prevents Endotoxemia-Induced Skel等 Muscle Wasting in Mice. Scientific Reports, 10, Article No. 694. [Google Scholar] [CrossRef] [PubMed]
[37] Yang, M., Fang, J., Zhang, N., Qin, L., Zhuang, Y., Wang, W., et al. (2021) Caspase‐1‐Inhibitor AC‐YVAD‐CMK Inhibits Pyroptosis and Ameliorates Acute Kidney Injury in a Model of Sepsis. BioMed Research International, 2021, Article ID: 6636621. [Google Scholar] [CrossRef] [PubMed]
[38] Liu, D., Huang, S., Sun, J., Zhang, H., Cai, Q., Gao, C., et al. (2022) Sepsis-Induced Immunosuppression: Mechanisms, Diagnosis and Current Treatment Options. Military Medical Research, 9, Article No. 56. [Google Scholar] [CrossRef] [PubMed]
[39] Nakamori, Y., Park, E.J. and Shimaoka, M. (2021) Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Frontiers in Immunology, 11, Article 624279. [Google Scholar] [CrossRef] [PubMed]
[40] Evans, L., Rhodes, A., Alhazzani, W., et al. (2021) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine, 49, e1063-e1143.
[41] Beale, R.J., Bryg, D.J. and Bihari, D.J. (1999) Immunonutrition in the Critically Ill: A Systematic Review of Clinical Outcome. Critical Care Medicine, 27, 2799-2805. [Google Scholar] [CrossRef] [PubMed]
[42] Hu, J., Deng, F., Sun, Q., Xiong, Q., Min, Y., Feng, S., et al. (2025) Time-Restricted Feeding Protects against Septic Liver Injury by Reshaping Gut Microbiota and Metabolite 3-Hydroxybutyrate. Gut Microbes, 17, Article ID: 2486515. [Google Scholar] [CrossRef] [PubMed]